TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Infectious Disease
Division of General Internal Medicine
National Taiwan University Hospital Yunlin Branch
Division of General Internal Medicine
更新時間：2023-09-19
洪健清HUNG, CHIEN-CHING
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
85Publications
31
Huang YS, Sun HY, Chang SY, Chuang YC, Cheng A, Huang SH, Huang YC, Chen GJ, Lin KY, Su YC, Liu WC, Hung CC. Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection. Hepatol Int. 2019 Jul;13(4):431-439. doi: 10.1007/s12072-019-09953-4. Epub 2019 Jun 8. PMID: 31177505.
32
Huang YC, Sun HY, Chuang YC, Huang YS, Lin KY, Huang SH, Chen GJ, Luo YZ, Wu PY, Liu WC, Hung CC, Chang SC. Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: real-world experience from a single-centre retrospective cohort in Taiwan. BMJ Open. 2019 Sep 20;9(9):e033246. doi: 10.1136/bmjopen-2019-033246. PMID: 31542770; PMCID: PMC6756335.
33
Hung TC, Chen GJ, Cheng SH, Chen JH, Wei JL, Cheng CY, Hung CC. Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression. J Microbiol Immunol Infect. 2019 Dec;52(6):865-871. doi: 10.1016/j.jmii.2019.07.002. Epub 2019 Aug 6. PMID: 31422059.
34
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Erratum in: Lancet. 2018 Nov 28;: PMID: 30420123.
35
Huang SH, Huang CH, Wang NC, Chen TC, Lee YT, Lin SP, Lin TY, Lin CY, Lee YL, Lee CH, Chen CP, Lin KY, Chen GJ, Liu CE, Cheng SH, Lu PL, Yang CJ, Hung CC; Taiwan HIV Study Group. Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: Incidence and Associated Factors. Hepatology. 2019 Aug;70(2):465-475. doi: 10.1002/hep.30495. Epub 2019 Feb 14. PMID: 30614542; PMCID: PMC6767446.
36
Lin TY, Yang CJ, Liu CE, Tang HJ, Chen TC, Chen GJ, Hung TC, Lin KY, Cheng CY, Lee YC, Lin SP, Tsai MS, Lee YL, Cheng SH, Hung CC, Wang NC; Taiwan HIV Study Group. Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study. J Microbiol Immunol Infect. 2019 Oct;52(5):700-709. doi: 10.1016/j.jmii.2018.01.005. Epub 2018 Mar 2. PMID: 29555411.
37
Chen GJ, Sun HY, Chang SY, Cheng A, Huang YS, Lin KY, Huang YC, Su YC, Liu WC, Hung CC. Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul;54(1):35-42. doi: 10.1016/j.ijantimicag.2019.03.016. Epub 2019 Mar 21. PMID: 30905695.
38
Liu WD, Tsai WC, Hsu WT, Shih MC, Chen MY, Sun HY, Hsieh SM, Sheng WH, Chuang YC, Cheng A, Lin KY, Huang YS, Huang SH, Huang YC, Chen GJ, Wu PY, Hung CC, Chang SC. Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan. J Microbiol Immunol Infect. 2020 Dec;53(6):936-945. doi: 10.1016/j.jmii.2019.03.008. Epub 2019 May 7. PMID: 31105037.
39
Lin JJ, Lin KY, Tang HJ, Lin SP, Lee YC, Liu CE, Huang YS, Wang NC, Li CW, Ko WC, Yang HJ, Lee YT, Hung CC; Taiwan HIV Study Group. Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan. J Microbiol Immunol Infect. 2021 Apr;54(2):228-237. doi: 10.1016/j.jmii.2019.10.005. Epub 2019 Oct 30. PMID: 31708481.
40
Tsai WC, Hsu WT, Liu WD, Sun HY, Chuang YC, Huang YS, Cheng A, Lin KY, Huang YC, Chen GJ, Huang SH, Sheng WH, Hsieh SM, Hung CC, Chang SC. Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection. Liver Int. 2019 Aug;39(8):1408-1417. doi: 10.1111/liv.14059. Epub 2019 Feb 17. PMID: 30712284.
